Similar articles

• Postmenopausal hormone therapy and risk of idiopathic venous thromboembolism: results from the E3N cohort study.

  Canonico M, Fournier A, Carcaillon L, Olié V, Plu-Bureau G, Oger E, Mesrine S, Boutron-Ruault MC, Clavel-Chapelon F, Scarabin PY. Canonico M, et al. Arterioscler Thromb Vasc Biol. 2010 Feb;30(2):340-5. doi: 10.1161/ATVBAHA.109.196022. Epub 2009 Oct 15. Arterioscler Thromb Vasc Biol. 2010. PMID: 19834106
• Increased thrombin generation among postmenopausal women using hormone therapy: importance of the route of estrogen administration and progestogens.

  Scarabin PY, Hemker HC, Clément C, Soisson V, Alhenc-Gelas M. Scarabin PY, et al. Menopause. 2011 Aug;18(8):873-9. doi: 10.1097/gme.0b013e31820eee88. Menopause. 2011. PMID: 21487317
• Transdermal and vaginal estradiol for the treatment of menopausal symptoms: the nuts and bolts.

  Kaunitz AM. Kaunitz AM. Menopause. 2012 Jun;19(6):602-3. doi: 10.1097/gme.0b013e31824c8a5a. Menopause. 2012. PMID: 22549171 No abstract available.
• [Hormone therapy and risk for venous thromboembolism in postmenopausal women].

  Lacut K, Oger E. Lacut K, et al. Rev Prat. 2005 Feb 28;55(4):389-92. Rev Prat. 2005. PMID: 15828617 Review. French.
• Hormone therapy and hemostasis among postmenopausal women: a review.

  Canonico M. Canonico M. Menopause. 2014 Jul;21(7):753-62. doi: 10.1097/GME.0000000000000296. Menopause. 2014. PMID: 24937030 Review.